| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.94B | 80.08B | 85.16B | 87.43B | 77.10B | 64.73B |
| Gross Profit | 32.51B | 29.52B | 32.94B | 35.67B | 29.74B | 21.62B |
| EBITDA | 12.89B | 11.04B | 13.78B | 18.27B | 14.24B | 8.98B |
| Net Income | 7.17B | 3.33B | 7.63B | 11.38B | 9.43B | 4.77B |
Balance Sheet | ||||||
| Total Assets | 102.35B | 108.58B | 105.77B | 101.37B | 86.26B | 74.92B |
| Cash, Cash Equivalents and Short-Term Investments | 21.69B | 23.23B | 24.06B | 18.76B | 13.93B | 14.31B |
| Total Debt | 5.45B | 6.49B | 5.97B | 4.26B | 2.25B | 2.81B |
| Total Liabilities | 25.72B | 26.99B | 27.51B | 29.70B | 25.08B | 23.09B |
| Stockholders Equity | 76.00B | 80.88B | 77.64B | 70.95B | 60.61B | 51.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.79B | 5.93B | 4.91B | 991.00M | 5.47B |
| Operating Cash Flow | 0.00 | 10.45B | 11.34B | 9.70B | 5.84B | 7.17B |
| Investing Cash Flow | 0.00 | -9.54B | -5.44B | -4.65B | -4.84B | -1.66B |
| Financing Cash Flow | 0.00 | -1.71B | -1.29B | -546.00M | -1.87B | -2.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥34.22B | 8.25 | ― | 3.59% | 6.27% | 28.43% | |
70 Outperform | ¥145.75B | 42.98 | ― | 2.17% | -5.97% | -55.87% | |
70 Outperform | ¥18.39B | 10.60 | ― | 3.09% | 1.55% | 15.00% | |
68 Neutral | ¥72.96B | 17.87 | ― | 3.27% | 5.30% | 15.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥15.41B | 8.45 | ― | 2.81% | 2.20% | 28.83% | |
55 Neutral | ¥99.91B | 40.41 | ― | 3.53% | -3.19% | -4.14% |